ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $41,000 | -43.8% | 44,551 | +22.8% | 0.00% | 0.0% |
| Q4 2019 | $73,000 | -30.5% | 36,271 | -1.8% | 0.00% | 0.0% |
| Q3 2019 | $105,000 | +1.0% | 36,931 | +171.7% | 0.00% | -50.0% |
| Q2 2019 | $104,000 | -41.2% | 13,595 | +2.0% | 0.00% | -33.3% |
| Q1 2019 | $177,000 | -13.7% | 13,325 | +1.0% | 0.00% | -25.0% |
| Q4 2018 | $205,000 | -18.0% | 13,195 | +3.4% | 0.00% | 0.0% |
| Q3 2018 | $250,000 | -43.3% | 12,762 | -17.1% | 0.00% | -50.0% |
| Q2 2018 | $441,000 | +23.2% | 15,387 | +1.6% | 0.01% | +14.3% |
| Q1 2018 | $358,000 | +79.9% | 15,147 | +62.7% | 0.01% | +40.0% |
| Q4 2017 | $199,000 | -8.7% | 9,307 | +0.8% | 0.01% | -54.5% |
| Q3 2017 | $218,000 | +20.4% | 9,237 | +0.3% | 0.01% | -8.3% |
| Q2 2017 | $181,000 | +69.2% | 9,207 | +79.8% | 0.01% | +50.0% |
| Q1 2017 | $107,000 | +15.1% | 5,120 | +2.6% | 0.01% | -11.1% |
| Q4 2016 | $93,000 | – | 4,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |